Topics

Latest "Research Down Syndrome" News Stories

05:45 EST 12th November 2019 | BioPortfolio

Here are the most relevant search results for "Research Down Syndrome" found in our extensive news archives from over 250 global news sources.

More Information about Research Down Syndrome on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Research Down Syndrome for you to read. Along with our medical data and news we also list Research Down Syndrome Clinical Trials, which are updated daily. BioPortfolio also has a large database of Research Down Syndrome Companies for you to search.

Showing "Research Down Syndrome" News Articles 1–25 of 22,000+

Relevant

New research links “broken heart syndrome” to cancer

Researchers have discovered a new link between broken-heart syndrome, or takotsubo syndrome, and the second leading cause of death in the world: cancer.


High rates of dementia, Alzheimer’s observed among older people with Down syndrome

NIH-funded study highlights need for research on aging Down syndrome population.

New NIH grant awards boost funding for research on Down syndrome

INCLUDE project aims to address conditions of Down syndrome and apply knowledge to larger population.


Retrophin Enters R&D Agreement with NCATS and the Alagille Syndrome Alliance to Identify Potential Therapeutics for Alagille Syndrome

SAN DIEGO, June 18, 2019 (GLOBE NEWSWIRE) — Retrophin, Inc. (NASDAQ: RTRX) today announced that it has entered into a three-way Cooperative Research and Development Agreement (CRADA) with the National Institutes of Health’s National Center for Advancing Translational Sciences (NCATS) and patient advocacy foundation Alagille Syndrome Alliance (ALGSA) to collaborate on research efforts aimed...

Retrophin Announces Cooperative Research and Development Agreement with NCATS and the Alagille Syndrome Alliance to Identify Potential Therapeutics for Alagille Syndrome

SAN DIEGO, June 18, 2019 (GLOBE NEWSWIRE) -- Retrophin, Inc. (NASDAQ: RTRX) today announced that it has entered into a three-way Cooperative Research and Development Agreement (CRADA) with the National Institutes of Health’s National Center for Advancing Translational Sciences (NCATS) and patient advocacy foundation Alagille Syndrome Alliance (ALGSA) to collaborate on research efforts aimed a...

Research advances to better target debilitating effects of cachexia syndrome

A study describes the generation of a new mouse model that could lead to a better understanding of the cachexia syndrome.

Job Research Foundation Awards Fourth Grant to Germany-Based Researcher to Investigate Causes of and Treatments for Job Syndrome

The Job Research Foundation has announced the fourth grant recipient of the first round of funding to support investigation into the causes of and treatments for Job Syndrome. NEW YORK (PRWEB) June 18, 2019 The Job Research Foundation is pleased to announce the fourth grant recipient of the first round of funding to support investigation into the causes of and treatments for Job Syndrome. The $20...

Waking 'sleeping' genes could help Prader-Willi syndrome

(Walter and Eliza Hall Institute) New funding is enabling Walter and Eliza Hall Institute researchers to develop new approaches to potentially help people with Prader-Willi syndrome, a devastating and incurable genetic condition.Research grants from the Prader-Willi Research Foundation of Australia and the US Foundation for Prader-Willi Research will enable Associate Professor Marnie Blewitt to in...

2019 Atypical Hemolytic Uremic Syndrome Nondiarrhea Associated Hemolytic Uremic Syndrome Clinical Trials Guide Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025 [Published by VPA Research] Prices from USD $1799

The global clinical trial report 2019 Atypical Hemolytic Uremic Syndrome Nondiarrhea Associated Hemolytic Uremic Syndrome Clinical Trials Study provides complete list of trials completed, ongoing and planned for Atypical Hemolytic Uremic Syndrome Nondiarrhea Associated Hemolytic Uremic Syndrome. It presents indepth analysis of Atypical Hemolytic Uremic Syndrome Nondiarrhea Associated Hemolytic Ur...

Too Much Drinking May Be Tied to PMS: Study

MONDAY, April 23, 2018 -- How much a woman indulges in alcohol may have ties to her premenstrual syndrome symptoms, a new global research review suggests. "We estimate that 11 percent of premenstrual syndrome (PMS) cases may be associated to...

OSU researcher expands research into deadly muscle-wasting syndrome

(Oregon State University) An Oregon State University scientist has received a $2.3 million, five-year grant to build on his promising research into a debilitating muscle-wasting syndrome that kills as many as 30% of the cancer patients it afflicts.

Massachusetts General Hospital First to Enroll Adults with Down Syndrome in New Nation-Wide Research Study Supported by LuMind IDSC Foundation

The Massachusetts General Hospital (MGH) Down Syndrome Program was the first approved research site in the first clinical trial in the Down Syndrome – Clinical Trials Network (DS-CTN) supported by LuMind IDSC Foundation. MGH is enrolling adults with Down Syndrome over the age of 25 in the Longitudinal Investigation for Enhancing Down Syndrome Research Study (LIFE-DSR) to better understand the he...

2019 Atypical Hemolytic Uremic Syndrome Nondiarrhea Associated Hemolytic Uremic Syndrome Clinical Trials Guide Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025 [Report Updated: 24042019] Prices from USD $1799

The global clinical trial report 2019 Atypical Hemolytic Uremic Syndrome Nondiarrhea Associated Hemolytic Uremic Syndrome Clinical Trials Study provides complete list of trials completed, ongoing and planned for Atypical Hemolytic Uremic Syndrome Nondiarrhea Associated Hemolytic Uremic Syndrome. It presents indepth analysis of Atypical Hemolytic Uremic Syndrome Nondiarrhea Associated Hemolytic Ur...

Dana-Farber Opens First Center Devoted to Lynch Syndrome

The new center will provide genetic testing, coordinated care, and research for individuals with Lynch syndrome. Medscape Medical News

Job Research Foundation Announces First Grant Recipients: Researchers from 3 Countries Selected to Receive Funding to Investigate Causes of & Treatments for Job Syndrome

The Job Research Foundation has announced the recipients of its first round of grant funding that will support investigation into the causes of and treatments for Job Syndrome. The Foundation awarded three two-year grants of $200,000 each to support research projects that will take place around the globe in three countries, and on three continents. NEW YORK (PRWEB) April 17, 2019 The Job Research...

Seizures Cut in Half After CBD Use in Dravet Syndrome

Two doses of a purified form of cannabidiol can significantly cut seizure frequency in kids with Dravet syndrome, new research says. Doses above 10 mg/kg/day "should be tailored to individual safety." Medscape Medical News

Stem cell therapy furthers research for infants with hypoplastic left heart syndrome

A phase I clinical trial is the first research monitored by the Food and Drug Administration that demonstrates the potential of regenerative therapy for hypoplastic left heart syndrome (HLHS) through collecting, processing and injecting an infant's own stem cells directly into the heart at the time of surgery.

2019 Down Syndrome Clinical Trials Guide Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025 [Published by VPA Research] Prices from USD $1799

The global clinical trial report 2019 Down Syndrome Clinical Trials Study provides complete list of trials completed, ongoing and planned for Down Syndrome. It presents indepth analysis of Down Syndrome clinical trials across markets and companies. The research work is for providing complete understanding into trends in Down Syndrome. The report covers a key snapshot of trial trends, enrollment t...

Medical News Today: What to know about urethral syndrome

Urethral syndrome, also known as urethral pain syndrome, can occur when the urethra becomes irritated. Symptoms can include urination difficulties and pain or discomfort in the lower abdomen. Learn more about the symptoms, risk factors, and treatment of urethral syndrome here.

Job Research Foundation Announces First Grant Recipients: Researchers from 3 Countries Selected to Receive Funding to Investigate Causes of & Treatments for Job Syndrome

NEW YORK (PRWEB) April 17, 2019 The Job Research Foundation has announced the recipients of its first round of grant funding that will support investigation into the causes of and treatments for Job Syndrome. The Foundation awarded three two-year grants of $200,000 each to support three...

Rettsyndrome.org funds research that will benefit boys and girls with MECP2-related disorders

Rettsyndrome.org announced their funding of two new research projects today. Jeannie T. Lee, MD, Ph.D. of Massachusetts General Hospital is awarded a two-year ANGEL Grant for $600,000 to focus on reactivating the silent X chromosome for Rett syndrome and Davut Pehlivan, MDof Baylor College of Medicine is awarded a two-year Mentored Clinical Fellowship for $250,000 to study MECP2 Duplication syndro...

Cancer preventive vaccine showed promising results in preclinical model of Lynch syndrome

(American Association for Cancer Research) Vaccination with as few as four tumor antigens generated antigen-specific responses, reduced intestinal tumors, and improved survival in a mouse model of Lynch syndrome, suggesting that it may be possible to develop a cancer preventive vaccine for patients with Lynch syndrome, according to data presented at the AACR Annual Meeting 2019, March 29-April 3.

A Promising New Treatment for Infants with Noonan Syndrome

NewsNoonan Syndrome is a rare genetic syndrome typically evident at birth and often linked to early-onset severe heart disease.Contributed Author:&

Cancer Drug A Promising New Treatment For Noonan Syndrome?

Scientists at the Université de Montréal and CHU Sainte-Justine Research Cente are said to have made a discovery, which could be a promising treatment for patients with Noonan Syndrome.

Doctors cure 'bubble boy syndrome' using modified version of HIV

Doctors at St. Jude Children’s Research Hospital have been able to treat patients with X-linked severe combined immunodeficiency (SCID-X1) – commonly known as ‘bubble boy syndrome’ – using a gene therapy based on HIV. SCID is a rare, life threatening genetic disorder which causes children to be born without a properly functioning immune system. Named bubble boy syndrome after the measure...


Quick Search

News Quicklinks